A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery
Trial details
- Registry ID
- NCT05549505
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as PF-07850327; Vepdegestrant
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryNCT05549505 | ARVN | Phase 2 | Completed | 2024-07-13Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |